恩威医药：关于与专业投资机构共同投资设立基金的公告

Core Points - Enwei Pharmaceutical announced a partnership with Shanghai Panlin Hongyu Enterprise Management Partnership and others to establish a venture capital fund [2] - The company will invest RMB 20 million, representing a 9.9502% stake in the fund [2] - This investment does not require approval from the company's board of directors or shareholders [2]